Skip to main content
. 2018 Jul 20;21(7):513–518. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2018.07.02

2.

Cox多因素分析

Cox multivariate analysis

Category PFS OS
HR (95%CI) P HR (95%CI) P
Age (yr) 1.531 (0.680-3.444) 0.304 0.847 (0.287-2.497) 0.764
Gender 0.376 (0.103-1.310) 0.123 0.565 (0.186-1.713) 0.313
Smoking status 2.806 (0.738-9.665) 0.130 2.350 (0.989-5.871) 0.097
EGFR mutation 0.882 (0.134-5.810) 0.896 0.551 (0.059-5.122) 0.600
ALK rearrangement 0.941 (0.164-5.388) 0.946 0.889 (0.158-4.984) 0.893
Driver mutation 0.933 (0.136-6.404) 0.943 1.470 (0.167-12.92) 0.728
Brain metastases 0.208 (0.492-1.045) 0.052 0.673 (0.364-1.548) 0.250
Bone metastases 1.593 (0.775-3.274) 0.205 2.540 (0.916-7.042) 0.073
Cycles of bevacizumab 0.290 (0.124-0.678) 0.004 1.297 (0.480-3.504) 0.608
Platinum-based regimens 0.814 (0.389-1.701) 0.584 0.650 (0.272-1.549) 0.331